½ÃÀ庸°í¼­
»óǰÄÚµå
1498724

ÀÚ°¡¹é½Å ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Å뺰, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)

Autogenous Vaccines Market, By Product Type, By Application, By Distribution, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 270 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÚ°¡¹é½Å ½ÃÀå ±Ô¸ð´Â 2023³â 1¾ï 3,092¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö CAGR 5.95%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚ°¡¹é½Å ½ÃÀå - ½ÃÀå ¿ªÇÐ

¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼º

ÀÚ°¡¹é½Å »ê¾÷Àº À¯¸®ÇÑ ½ÃÀå ¿ªÇп¡µµ ºÒ±¸Çϰí ÁöÀûÀç»ê±Ç, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ±â¼úÀû ÇѰè¿Í °ü·ÃµÈ Àå¾Ö¹°¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÚ°¡¹é½ÅÀº ¹Ì±¹ ³ó¹«ºÎÀÇ ¼öÀÇÇÐ ¼­ºñ½º Áöħ(Veterinary Service Memorandum Guidelines for Autogenous Biologics)ÀÌ Àû¿ëµË´Ï´Ù. ÀÚ°¡¹é½ÅÀº Ưº°È÷ Á¦Á¶µÈ ºÒȰ¼ºÈ­ ¹é½ÅÀ¸·Î, ¼öÀÇ»ç ¶Ç´Â ±âŸ °øÀÎµÈ Àü¹®°¡¿¡ ÀÇÇØ¼­¸¸ Á¢Á¾µË´Ï´Ù. ¿µ±¹¿¡¼­ ÆÇ¸ÅµÇ´Â µ¿¹°¿ë ÀǾàǰÀÇ À¯È¿¼º, ¾ÈÀü¼º ¹× ǰÁúÀ» º¸ÀåÇϴ åÀÓ ±â°üÀº ¼öÀǾ౹(Veterinary Medicines Directorate)ÀÔ´Ï´Ù. ¸é¿ªÇÐ ÆÀÀº ¸é¿ªÇÐ Á¦Á¦¸¦ Á¦Á¶ÇÏ´Â ½Ã¼³À» °Ë»çÇÏ°í ¸é¿ªÇÐ Á¦Á¦ÀÇ ÆÇ¸Å ½ÂÀÎ ½ÅûÀ» Æò°¡ÇÕ´Ï´Ù. Á¦Á¶ ÀýÂ÷´Â ÀÚ°¡¹é½ÅÀÇ Ç°Áú°ú ½ÃÀå °¡¿ë¼º¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¡Àå Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. Á¦Á¶ ÀýÂ÷´Â ±ÔÁ¦ ¿ä°Ç¿¡ µû¶ó ÃÖÀûÈ­µÇ¾î ÀÖ½À´Ï´Ù.

ÀÚ°¡¹é½Å ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¾à 5.95%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â Bacterial Autogenous Vaccines°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¾ú½À´Ï´Ù.

¿ëµµº°·Î´Â °¡Ãà¿ë ¹é½ÅÀÌ 2023³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â µ¿¹°º´¿øÀÌ 2023³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

À¯Åë ºÎ¹®º°·Î´Â Á÷ÆÇÀÌ 2023³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â À¯·´ÀÌ 2023³â ¸ÅÃâ¿¡¼­ ¼±µÎ¸¦ Â÷ÁöÇß½À´Ï´Ù.

ÀÚ°¡¹é½Å ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

¼¼°è ÀÚ°¡¹é½Å ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, À¯Åë, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó °¡Ãà ¹é½Å, ¹Ý·Áµ¿¹° ¹é½Å, ¾ç½Ä ¹é½Å µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Áúº´ À§ÇùÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ °¡Ãà°ú °¡±Ý·ù °³Ã¼¼ö°¡ ¸¹Àº ´ë±Ô¸ð ³ó°¡´Â Àü¹®ÀûÀÎ ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥À» ½Ç½ÃÇØ¾ß ÇÕ´Ï´Ù. ¹ÙÀÌ¿À º¸¾È ÇÁ·ÎÅäÄÝÀ» °³¼±Çϰí Áö¼Ó°¡´ÉÇÑ ³ó¹ýÀ» º¸ÀåÇÏ·Á´Â ´ë±Ô¸ð ³óÀåÀº ƯÈ÷ ¸ÂÃãÇü ¿¹¹æ Á¢Á¾ Àü·«À» ½ÃÇàÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ¼¼±Õ¼º ÀÚ°¡¹é½Å, ¹ÙÀÌ·¯½º¼º ÀÚ°¡¹é½Å, ±âŸÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´µ¸ç, 2023³â ¾ç½Ä¾î·ù ÀÚ°¡¹é½Å ½ÃÀåÀº ¼¼±Õ ºÐ¾ß°¡ ½ÃÀåÀÇ 80% ÀÌ»óÀ» Â÷ÁöÇϸç ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¿¡¾î·Î¸ð³ª½º, ¿¬¼â»ó±¸±Õ, ºñºê¸®¿À¿Í °°Àº ¹ÚÅ׸®¾Æ°¡ Áúº´À» À¯¹ßÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚ°¡¹é½ÅÀº ƯÁ¤ ¾ç½ÄÀå¿¡ Á¸ÀçÇÏ´Â ¹Ì»ý¹°À» ÅðÄ¡Çϱâ À§ÇØ Æ¯º°È÷ ¼³°èµÇ¾ú±â ¶§¹®¿¡ µ¶Æ¯ÇÕ´Ï´Ù. µû¶ó¼­ Áúº´À» ¸·´Â µ¥ Ź¿ùÇÕ´Ï´Ù. ¾ç½Ä¾÷ÀÚµéÀº »ý»ê¿¡¼­ »ç¿ë±îÁö ºü¸¥ ÀÌ ¹é½ÅÀ» ¼±È£ÇÏ°Ô µÇ¾ú½À´Ï´Ù.

ÀÚ°¡¹é½Å ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

µ¿¹°¿ë »ý¹°ÇÐÀû Á¦Á¦ ¹× Á¦¾à »ê¾÷ÀÇ ¿¬±¸ ³ë·Â Áõ°¡¿Í µ¿¹° °Ç°­ °ü¸® °ü·Ã ºñ¿ë Áõ°¡·Î ÀÎÇØ À¯·´Àº ÇöÀç ÀÚ°¡¹é½Å ¼¼°è ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¹°¿ë ¹é½ÅÀÇ »ç¿ë Áõ°¡¿Í µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ¼öÀͼºÀÌ ³ôÀº Áö¿ª Áß ÇϳªÀ̸ç, ±¹Á¦ ±â¾÷µé¿¡°Ô ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â Àü¿°º´ÀÇ À§Çè Áõ°¡¿Í Áúº´¿¡ °É¸° µ¿¹°ÀÇ ¼ö°¡ ¸¹±â ¶§¹®¿¡ ÀÚ°¡¹é½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚ°¡¹é½Å ½ÃÀå - °æÀï »óȲ:

ÀÚ°¡¹é½Å ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â IDT Biologika GmbH, MARINNOVAC, Ceva Biovac, HIPRA, AniCon Labor GmbH, Kennebec River Biosciences µîÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä °æÀï»çµéÀº ¾÷°è ³» ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ Á¦ÈÞ, Á¦Ç° Ãâ½Ã, ÀμöÇÕº´, »ç¾÷ È®Àå µîÀÇ Àü¼ú¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Newport Laboratories¿Í °°Àº ±â¾÷µéÀº ´õ ³ÐÀº °í°´Ãþ¿¡ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ Á¦Ç°À» ´Ù¾çÈ­ÇÏ°í »õ·Î¿î °í°´Ãþ¿¡ Á¢±ÙÇϰí ÀÖÀ¸¸ç, Ceva Sante Animale, Phibro Animal Health, Zoetis¿Í °°Àº ÁÖ¿ä ±â¾÷µéÀº ±¤¹üÀ§ÇÑ ¿¬±¸ ¹× °³¹ß ¿ª·®À» º¸À¯Çϰí ÀÖ½À´Ï´Ù. Ceba Sante Animale, Phibro Animal Health, Zoetis¿Í °°Àº ´ëÇü ±â¾÷µéÀº ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ß ´É·Â°ú ±¤¹üÀ§ÇÑ ÆÇ¸Å¸ÁÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ƯÈ÷ °¡Ãà ¼ö°¡ ¸¹°í ƯÁ¤ Áúº´ ¹®Á¦°¡ ÀÖ´Â Áö¿ª¿¡¼­´Â ÇöÁö ¹× Áö¿ª Á¦Á¶¾÷üµµ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. À̵é Á¦Á¶¾÷ü´Â ÇØ´ç Áö¿ªÀÇ Áúº´ À¯Çà »óȲÀ» ±íÀÌ ÀÌÇØÇÏ°í ±×¿¡ µû¶ó ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÚ°¡¹é½Å ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ÀÚ°¡¹é½ÅÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀå Àü¸Á µ¿Çâ

Á¦4Àå ÀÚ°¡¹é½Å »ê¾÷ Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ºÐ¼®

Á¦5Àå ÀÚ°¡¹é½Å ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÚ°¡¹é½Å ½ÃÀå »óȲ

  • ÀÚ°¡¹é½Å ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½ÅÈï ±â¾÷ ºÐ¼®

Á¦7Àå ÀÚ°¡¹é½Å ½ÃÀå : Á¦Ç° À¯Çüº°

  • °³¿ä
    • Á¦Ç° À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¼¼±Õ¼º ÀÚ°¡¹é½Å
    • ¹ÙÀÌ·¯½º¼º ÀÚ°¡¹é½Å
    • ±âŸ

Á¦8Àå ÀÚ°¡¹é½Å ½ÃÀå : ¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • °¡Ãà ¹é½Å
    • ¹Ý·Áµ¿¹°¿ë ¹é½Å
    • ¼ö»ê¾ç½Ä ¹é½Å

Á¦9Àå ÀÚ°¡¹é½Å ½ÃÀå : À¯Å뺰

  • °³¿ä
    • À¯Å뺰 ºÎ¹® Á¡À¯À² ºÐ¼®
    • Á÷Á¢ ÆÇ¸Å
    • ´ë¸®Á¡ ÆÇ¸Å
    • ¿Â¶óÀÎ ÆÇ¸Å

Á¦10Àå ÀÚ°¡¹é½Å ½ÃÀå : ±â¼úº°

  • °³¿ä
    • ±â¼úº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ºÒȰȭ ¹é½Å
    • »ý¾àµ¶È­ ¹é½Å
    • ¾Æ´ÜÀ§ ¹é½Å
    • Åå¼ÒÀÌµå ¹é½Å

Á¦11Àå ÀÚ°¡¹é½Å ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
    • ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¼öÀÇ Å¬¸®´Ð
    • µ¿¹° º´¿ø
    • µ¿¹°³óÀå
    • ¼ö»ê¾ç½ÄÀå

Á¦12Àå ÀÚ°¡¹é½Å ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÀÚ°¡¹é½Å ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • IDT Biologika GmbH
    • MARINNOVAC
    • Ceva Biovac
    • Zoetis(PHARMAQAS)
    • Vaxxinova
    • Barramundi Asia Pte Ltd.(UVAXX Asia)
    • HIPRA
    • AniCon Labor GmbH
    • sanphar(ipeve)
    • Kennebec River Biosciences
    • Others

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm 24.06.27

REPORT HIGHLIGHT

Autogenous Vaccines Market size was valued at USD 130.92 Million in 2023, expanding at a CAGR of 5.95% from 2024 to 2032.

The rise in infectious diseases among livestock and companion animals drives the demand for autogenous vaccines. These vaccines are crucial for managing outbreaks caused by unique or region-specific pathogens. The ability to customize vaccines to target specific strains in a particular herd or flock increases their effectiveness, making them an attractive option for veterinarians and farmers. The increasing trend of pet ownership and the willingness of pet owners to invest in preventive healthcare for their animals create opportunities for the development and sale of autogenous vaccines for companion animals.

Autogenous Vaccines Market- Market Dynamics

Stringent Regulatory Frameworks Potentially Impede the Market Growth

The autogenous vaccine industry is confronted with obstacles regarding intellectual property rights, regulatory frameworks, and technological limitations, even with its advantageous market dynamics. Regulations and the USDA's Veterinary Service Memorandum Guidelines for Autogenous Biologics apply to autogenous vaccines. These are specially prepared inactivated vaccinations that can only be administered by veterinarians or other authorized professionals. In the United Kingdom, the responsible authority for guaranteeing the effectiveness, safety, and quality of veterinary pharmaceuticals sold is the Veterinary Medicines Directorate. The Immunological team is in charge of inspecting the production facilities that generate immunological products and evaluating immunological applications for marketing authorizations. Manufacturing procedures are the most important factor affecting the quality of autogenous vaccines and their availability on the market. They are optimized by regulatory requirements.

Autogenous Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.95% over the forecast period (2024-2032)

Based on product type segmentation, Bacterial Autogenous Vaccines was predicted to show maximum market share in the year 2023

Based on application segmentation, Livestock Vaccines was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on distribution segmentation, Direct Sales was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Autogenous Vaccines Market- Segmentation Analysis:

The Global Autogenous Vaccines Market is segmented on the basis of Product Type, Application, Distribution, Technology, End User, and Region.

The market is divided into three categories based on application: Livestock Vaccines, Companion Animal Vaccines, and Aquaculture Vaccines. To effectively manage disease threats, large-scale farming operations with significant populations of cattle or poultry need to implement specialized vaccination programs. Large farms looking to improve biosecurity protocols and guarantee sustainable farming practices are especially likely to implement customized immunization strategies.

The market is divided into three categories based on product type: Bacterial Autogenous Vaccines, Viral Autogenous Vaccine, and Others. With more than 80% of the market, the bacterium segment of the autogenous vaccine market for fish farming led the way in 2023. Since bacteria like Aeromonas, Streptococcus, and Vibrio are frequently the cause of illness, there is a growing demand for vaccines specifically designed to combat these issues. Because they are specifically designed to combat the microorganisms present in a particular fish farm, autogenous vaccines are unique. They are therefore excellent at halting illnesses. Fish growers have come to love these vaccines because of how quickly they can be manufactured and used.

Autogenous Vaccines Market- Geographical Insights

Due to rising research efforts in the veterinary biologics and medicine industries and rising costs associated with providing animal healthcare, Europe is currently leading the world market for autogenous vaccines. Additionally, the market has grown as a result of the rising use of animal vaccines and rising awareness of animal health. Furthermore, Asia Pacific is among the most lucrative regions and is creating opportunities for international firms. The need for autogenous vaccines may rise in these areas due to the rising risk of infectious diseases and the high population of sick animals.

Autogenous Vaccines Market- Competitive Landscape:

Key Players in the Autogenous Vaccines Market include IDT Biologika GmbH, MARINNOVAC, Ceva Biovac, HIPRA, AniCon Labor GmbH, Kennebec River Biosciences etc. To improve their position in the industry, major competitors are concentrating on tactics including collaborations, product launches, mergers and acquisitions, and expansions. To serve a wider client base, businesses such as Newport Laboratories and others are, for instance, diversifying their product offerings and reaching out to new demographics. Major players like Ceva Sante Animale, Phibro Animal Health, and Zoetis are prominent due to their extensive research and development capabilities and broad distribution networks. Local and regional manufacturers also play a crucial role, particularly in regions with high livestock populations and specific disease challenges. These players often deeply understand local disease prevalence and tailor their solutions accordingly.

Recent Developments:

In February 2021, Philippe Mauguin, CEO of INRAE, and Dr. Marc Prikazsky, Chairman & CEO of Ceva Sante Animale, signed a first framework agreement to consolidate their collaboration in animal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTOGENOUS VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

IDT Biologika GmbH

MARINNOVAC

Ceva Biovac

Zoetis (PHARMAQAS)

Vaxxinova

Barramundi Asia Pte Ltd. (UVAXX Asia)

HIPRA

AniCon Labor GmbH

sanphar (ipeve)

Kennebec River Biosciences

Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bacterial Autogenous Vaccines
  • Viral Autogenous Vaccine
  • Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Livestock Vaccines
  • Companion Animal Vaccines
  • Aquaculture Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Direct Sales
  • Distributor Sale
  • Online Sale

GLOBAL AUTOGENOUS VACCINES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Clinic
  • Veterinary Hospitals
  • Animal Farms
  • Aquaculture Farms

GLOBAL AUTOGENOUS VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Autogenous Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Autogenous Vaccines Market Snippet by Product Type
    • 2.1.2. Autogenous Vaccines Market Snippet by Application
    • 2.1.3. Autogenous Vaccines Market Snippet by Distribution
    • 2.1.4. Autogenous Vaccines Market Snippet by Technology
    • 2.1.5. Autogenous Vaccines Market Snippet by End User
    • 2.1.6. Autogenous Vaccines Market Snippet by Country
    • 2.1.7. Autogenous Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Autogenous Vaccines Key Market Trends

  • 3.1. Autogenous Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Autogenous Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Autogenous Vaccines Market Opportunities
  • 3.4. Autogenous Vaccines Market Future Trends

4. Autogenous Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Autogenous Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Autogenous Vaccines Market Landscape

  • 6.1. Autogenous Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Autogenous Vaccines Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Bacterial Autogenous Vaccines
    • 7.1.3. Viral Autogenous Vaccine
    • 7.1.4. Others

8. Autogenous Vaccines Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Livestock Vaccines
    • 8.1.3. Companion Animal Vaccines
    • 8.1.4. Aquaculture Vaccines

9. Autogenous Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Direct Sales
    • 9.1.3. Distributor Sale
    • 9.1.4. Online Sale

10. Autogenous Vaccines Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Inactivated Vaccines
    • 10.1.3. Live Attenuated Vaccines
    • 10.1.4. Subunit Vaccines
    • 10.1.5. Toxoid Vaccines

11. Autogenous Vaccines Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Veterinary Clinic
    • 11.1.3. Veterinary Hospitals
    • 11.1.4. Animal Farms
    • 11.1.5. Aquaculture Farms

12. Autogenous Vaccines Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Autogenous Vaccines Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Autogenous Vaccines Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Autogenous Vaccines Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Autogenous Vaccines Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Autogenous Vaccines Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Autogenous Vaccines Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. IDT Biologika GmbH
    • 13.2.2. MARINNOVAC
    • 13.2.3. Ceva Biovac
    • 13.2.4. Zoetis (PHARMAQAS)
    • 13.2.5. Vaxxinova
    • 13.2.6. Barramundi Asia Pte Ltd. (UVAXX Asia)
    • 13.2.7. HIPRA
    • 13.2.8. AniCon Labor GmbH
    • 13.2.9. sanphar (ipeve)
    • 13.2.10. Kennebec River Biosciences
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦